Efficacy of Targeted Mast cell Inhibition Therapy in Chronic Prostatitis/Chronic Pelvic Pain Syndrome.

[1]  A. Schaeffer,et al.  Mast cell function in prostate inflammation, fibrosis, and smooth muscle cell dysfunction. , 2021, American journal of physiology. Renal physiology.

[2]  V. Rivero,et al.  Patients with chronic prostatitis/chronic pelvic pain syndrome show T helper type 1 (Th1) and Th17 self‐reactive immune responses specific to prostate and seminal antigens and diminished semen quality , 2020, BJU international.

[3]  J. Christianson,et al.  Differential Influence of Early Life and Adult Stress on Urogenital Sensitivity and Function in Male Mice , 2018, Front. Syst. Neurosci..

[4]  D. Elmaleh,et al.  Pharmacokinetics of Cromolyn and Ibuprofen in Healthy Elderly Volunteers , 2017, Clinical Drug Investigation.

[5]  P. Tugwell,et al.  CONSORT 2010 statement: extension to randomised pilot and feasibility trials , 2016, British Medical Journal.

[6]  D. Shoskes,et al.  Chronic prostatitis/chronic pelvic pain syndrome: a review of evaluation and therapy , 2016, Prostate Cancer and Prostatic Diseases.

[7]  A. Schaeffer,et al.  Tryptase-PAR2 axis in experimental autoimmune prostatitis, a model for chronic pelvic pain syndrome , 2014, PAIN®.

[8]  A. Schaeffer,et al.  Th1-Th17 Cells Contribute to the Development of Uropathogenic Escherichia coli-Induced Chronic Pelvic Pain , 2013, PloS one.

[9]  A. Fagin,et al.  Therapeutic Intervention for Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS): A Systematic Review and Meta-Analysis , 2012, PloS one.

[10]  A. Schaeffer,et al.  Role of mast cells in male chronic pelvic pain. , 2012, The Journal of urology.

[11]  S. K. Van Den Eeden,et al.  Contribution of common medications to lower urinary tract symptoms in men. , 2011, Archives of internal medicine.

[12]  M. Benhamou,et al.  Mast Cells as Cellular Sensors in Inflammation and Immunity , 2011, Front. Immun..

[13]  Stephen A. Allsop,et al.  The Role of Phenotyping in Chronic Prostatitis/Chronic Pelvic Pain Syndrome , 2011, Current urology reports.

[14]  S. Iwata,et al.  Histamine H1‐receptor antagonists with immunomodulating activities: potential use for modulating T helper type 1 (Th1)/Th2 cytokine imbalance and inflammatory responses in allergic diseases , 2009, Clinical and experimental immunology.

[15]  Jennifer L. Osborn,et al.  Direct multiplexed measurement of gene expression with color-coded probe pairs , 2008, Nature Biotechnology.

[16]  M. Pontari,et al.  Responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) , 2006, Quality of Life Research.

[17]  M. Barry,et al.  Prevalence and correlates of prostatitis in the health professionals follow-up study cohort. , 2002, The Journal of urology.

[18]  L. Schwartz.  Clinical utility of tryptase levels in systemic mastocytosis and associated hematologic disorders. , 2001, Leukemia research.

[19]  M. Barry,et al.  The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. , 1992, The Journal of urology.

[20]  K. Amin.  The role of mast cells in allergic inflammation. , 2012, Respiratory medicine.

[21]  JoVE Video Dataset , 2022 .